Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
23.76B | 23.73B | 22.56B | 20.81B | 19.20B | 29.15B | Gross Profit |
11.53B | 11.25B | 10.81B | 9.72B | 7.91B | 12.50B | EBIT |
406.00M | 518.00M | 293.00M | 159.00M | -2.18B | -727.00M | EBITDA |
848.50M | 1.00B | 546.00M | 376.00M | -3.59B | -431.00M | Net Income Common Stockholders |
425.00M | 427.00M | 491.00M | 138.00M | -4.42B | -1.30B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.62B | 5.20B | 6.73B | 7.97B | 6.89B | 3.29B | Total Assets |
25.81B | 27.80B | 27.50B | 27.38B | 27.87B | 28.70B | Total Debt |
9.32B | 10.59B | 10.55B | 11.40B | 11.93B | 6.10B | Net Debt |
5.70B | 5.39B | 3.82B | 3.43B | 5.04B | 2.81B | Total Liabilities |
13.46B | 15.35B | 16.54B | 17.10B | 17.59B | 14.34B | Stockholders Equity |
12.35B | 12.42B | 10.93B | 10.25B | 10.26B | 14.33B |
Cash Flow | Free Cash Flow | ||||
0.00 | -1.52B | -821.00M | 1.36B | -2.69B | -799.00M | Operating Cash Flow |
0.00 | -1.05B | 102.00M | 1.54B | -2.50B | -435.00M | Investing Cash Flow |
0.00 | -296.00M | -485.00M | 45.00M | 445.00M | -393.00M | Financing Cash Flow |
0.00 | -186.00M | -884.00M | -593.00M | 5.67B | 411.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥160.44B | 11.93 | 2.57% | 10.09% | 33.98% | ||
76 Outperform | ¥7.68B | 32.17 | 4.28% | -3.35% | -41.42% | ||
71 Outperform | ¥8.15B | 15.64 | 2.50% | 3.89% | 10.91% | ||
70 Outperform | ¥7.88B | 11.27 | 3.04% | -0.73% | 63.91% | ||
62 Neutral | $6.84B | 11.41 | 2.80% | 3.87% | 2.70% | -24.58% | |
62 Neutral | ¥7.76B | 14.50 | 3.04% | 6.11% | 3541.59% | ||
50 Neutral | ¥7.89B | ― | 2.11% | -9.83% | -371.31% |